Eli Lilly
Stéphane Bancel: Leading Moderna’s Evolution and Innovation
Stéphane Bancel, born on July 20, 1972, in Marseille, France, has emerged as a pivotal figure in the biotechnology sector. Currently serving as...
Stéphane Bancel: The Visionary Leader Behind Moderna’s Revolution
Stéphane Bancel is one of the most transformative figures in modern biotechnology, known for his pivotal role as the CEO of Moderna, the...
Eli Lilly Cuts Zepbound Price by 50% for Self-Pay Patients
Eli Lilly has unveiled a new program aimed at making its weight-loss drug, Zepbound, more accessible to self-pay patients by offering it at...
FDA Greenlights Eli Lilly’s Alzheimer’s Drug Donanemab
On Tuesday, the Food and Drug Administration (FDA) granted approval for Eli Lilly’s Alzheimer’s drug, donanemab, marking a significant milestone in the treatment...
Zealand Pharma Shares Surge 17% on Positive Drug Trial
Shares of Zealand Pharma soared by over 17% on Friday following the announcement of positive trial results for petrelintide, a potential competitor to...
Eli Lilly’s Zepbound Reduces Sleep Apnea in Obese Adults
Eli Lilly’s Zepbound, a weight loss drug, showed promise in treating sleep apnea in obese adults, the company announced Wednesday. Results from late-stage...
